How Do Medication Management Interventions Reduce Polypharmacy- Related Risks In Older Adults With Multiple Chronic Conditions?
Keywords:
Polypharmacy, older adults, medication management, deprescribing, chronic conditions, systematic reviewAbstract
Introduction: Polypharmacy, defined as the concurrent use of five or more medications, is prevalent among older adults with multiple chronic conditions, increasing the risk of adverse drug events and diminished quality of life. Addressing these risks through effective medication management has become a critical healthcare priority. Methods: This systematic review evaluated 40 studies, primarily randomized controlled trials (RCTs), focusing on medication management interventions such as structured medication reviews, deprescribing protocols, and electronic decision support systems. The inclusion criteria targeted older adults aged 65 years and above, taking five or more medications. Results: The review revealed that medication management interventions significantly reduced the number of medications and potentially inappropriate medications (PIMs). Notably, 10 out of 14 studies reported a decrease in medication counts, and 5 out of 8 studies showed reductions in PIMs. Clinical benefits included improved quality-adjusted life years and fewer hospital admissions. Discussion: A multidisciplinary approach, involving pharmacists, physicians, and nurses, was essential for the success of these interventions. The integration of technology and patient-centered strategies enhanced medication adherence and safety. However, challenges such as time constraints and resource intensity hindered broader implementation. Conclusion: Medication management interventions effectively reduce polypharmacy-related risks in older adults. Continued focus on multidisciplinary collaboration, technology integration, and addressing implementation barriers is crucial for optimizing medication safety and health outcomes.References
A. Green, E. Bayliss, S. Shetterly, Melanie L. Drace, J. Norton, E. Reeve, O. Sheehan, and C. Boyd. “Results of Optimize: A Cluster Randomized Trial of Patient, Family, and Provider Education in Primary Care.” Innovation in Aging, 2021.
A. Mortsiefer, S. Wilm, S. Santos, S. Löscher, A. Wollny, E. Drewelow, M. Ritzke, et al. “Family Conferences and Shared Prioritisation to Improve Patient Safety in the Frail Elderly (COFRAIL): Study Protocol of a Cluster Randomised Intervention Trial in Primary Care.” Trials, 2020.
A. Sönnichsen, U. Trampisch, Anja Rieckert, G. Piccoliori, Anna Vögele, M. Flamm, T. Johansson, et al. “Polypharmacy in Chronic Diseases–Reduction of Inappropriate Medication and Adverse Drug Events in Older Populations by Electronic Decision Support (PRIMA-eDS): Study Protocol for a Randomized Controlled Trial.” Trials, 2016.
Aisling Croke, F. Moriarty, F. Boland, L. McCullagh, Karen Cardwell, Susan M. Smith, and B. Clyne. “Integrating Clinical Pharmacists Within General Practice: Protocol for a Pilot Cluster Randomised Controlled Trial.” BMJ Open, 2021.
Anne Holbrook, Dan Perri, Mitch Levine, Lawrence Mbuagbaw, Sarah Jarmain, L. Thabane, J. Tarride, et al. “Improving Medication Prescribing-Related Outcomes for Vulnerable Elderly in Transitions on High-Risk Medications (IMPROVE-IT HRM): A Pilot Randomized Trial Protocol.” medRxiv, 2023.
Antonio San-José, C. Pérez-Bocanegra, A. Agustí, Helena Laorden, J. Gost, X. Vidal, Vanessa Oropeza, and Rosa Romero. “Integrated Health Intervention on Polypharmacy and Inappropriate Prescribing in Elderly People with Multimorbidity: Results at the End of the Intervention and at 6 Months After the Intervention.” Medicina Clínica (Ed. Impresa), 2020.
C. Huibers, B. T. Sallevelt, J. M. J. O. Heij, D. O’Mahony, N. Rodondi, O. Dalleur, R. V. van Marum, A. Egberts, I. Wilting, and W. Knol. “Hospital Physicians’ and Older Patients’ Agreement with Individ- ualised STOPP/START-Based Medication Optimisation Recommendations in a Clinical Trial Setting.” European Geriatric Medicine, 2022.
C. Kinahan, Nazir Soomro, F. Daniels, Wafaa A. Hussain, and H. Heery. “43 Addressing Polypharmacy in the Frail Older Person - the WIDE (Wholistic, Integrated, Deprescribing, Evaluation) Review.” Age and Ageing, 2019.
C. McCarthy, B. Clyne, F. Boland, F. Moriarty, M. Flood, E. Wallace, and Susan M. Smith. “GP-Delivered Medication Review of Polypharmacy, Deprescribing, and Patient Priorities in Older People with Mul- timorbidity in Irish Primary Care (SPPiRE Study): A Cluster Randomised Controlled Trial.” PLoS Medicine, 2022.
Carol Rovira, P. Modamio, Joaquim Pascual, J. Armengol, Cristián Ayala, Joan Gallego, E. Mariño, and A. Ramirez. “Person-Centred Care Provided by a Multidisciplinary Primary Care Team to Improve Ther- apeutic Adequacy in Polymedicated Elderly Patients (PCMR): Randomised Controlled Trial Protocol.” BMJ Open, 2022.
D. Garfinkel. “Poly-de-Prescribing to Treat Polypharmacy: Efficacy and Safety.” Therapeutic Advances in Drug Safety, 2018.
D. Garfinkel, and Yuval Levy. “Optimizing Clinical Outcomes in Polypharmacy Through Poly-de- Prescribing: A Longitudinal Study.” Frontiers in Medicine, 2024.
D. Mangin, L. Lamarche, G. Agarwal, Abbas Ali, A. Cassels, Kiska Colwill, L. Dolovich, et al. “Team Approach to Polypharmacy Evaluation and Reduction: Feasibility Randomized Trial of a Structured Clinical Pathway to Reduce Polypharmacy.” Pilot and Feasibility Studies, 2023.
E. Bayliss, S. Shetterly, M. Drace, J. Norton, A. Green, E. Reeve, L. Weffald, et al. “The OPTIMIZE Patient- and Family-Centered, Primary Care-Based Deprescribing Intervention for Older Adults with Dementia or Mild Cognitive Impairment and Multiple Chronic Conditions: Study Protocol for a Pragmatic Cluster Randomized Controlled Trial.” Trials, 2020.
Erin K. Crowley, B. T. Sallevelt, C. Huibers, K. Murphy, M. Spruit, Zhengru Shen, B. Boland, et al. “Intervention Protocol: OPtimising thERapy to Prevent Avoidable Hospital Admission in the Multi- Morbid Elderly (OPERAM): A Structured Medication Review with Support of a Computerised Decision Support System.” BMC Health Services Research, 2020.
F. Pereira, M. Dixe, Sónia Gonçalves Pereira, C. Meyer-Massetti, and H. Verloo. “An Intervention Program to Reduce Medication-Related Problems Among Polymedicated Home-Dwelling Older Adults (OptiMed): Protocol for a Pre-Post, Multisite, Pilot, and Feasibility Study.” JMIR Research Protocols, 2022.
Hye Jun Lee, S. Jang, Ju-yeun Lee, Young-Mi Ah, Mi-Kyung Lee, Suhyun Jang, Sena An, and Jung-ha Kim. “Development of a Multidisciplinary Medication Management Program in Nursing Homes: Protocol for a Randomized Controlled Trial.” BMC Geriatrics, 2024
I. Redondo, A. Fullaondo, María Dolores Martinez, Ricardo Samper, Carmela Mozo, Elena Valverde, and E. M. Keenoy. “Integration of a Web Application in Osakidetza Basque Health Service Information System to Optimize and Adapt Pharmacy Therapeutic of Multimorbid Patients.” International Journal of Integrated Care, 2023.
I. Schäfer, H. Kaduszkiewicz, C. Mellert, Christin Löffler, A. Mortsiefer, A. Ernst, C. Stolzenbach, et al. “Narrative Medicine-Based Intervention in Primary Care to Reduce Polypharmacy: Results from the Cluster-Randomised Controlled Trial MultiCare AGENDA.” BMJ Open, 2018.
Isabel del Cura-González, J. A. López-Rodríguez, F. Leiva-Fernández, L. Gimeno-Feliú, V. Pico-Soler, Mª Josefa Bujalance-Zafra, Miguel Domínguez-Santaella, et al. “Effectiveness of the MULTIPAP Plus Inter- vention in Youngest-Old Patients with Multimorbidity and Polypharmacy Aimed at Improving Prescrib- ing Practices in Primary Care: Study Protocol of a Cluster Randomized Trial.” Trials, 2022.
J. Richter, M. Schönfeld, C. Langebrake, C. Bergelt, L. Kriston, C. Olotu, and R. Kiefmann. “Pharmaceutical Management of Elderly High-Risk Patients in Perioperative Settings (PHAROS): Protocol of a Pilot Sequential Intervention Study.” BMJ Open, 2020.
Jesús Martínez-Sotelo, Manel Pinteño-Blanco, R. García-Ramos, and María Isabel Cadavid-Torres. “Ade- cuación de La Prescripción En Pacientes Mayores Polimedicados En Atención Primaria. Ensayo Clínico Controlado Aleatorizado Por Grupos PHARM-PC.” Atención Primaria, 2021.
K. Jungo, P. Salari, Rahel Meier, M. Bagattini, Marco Spruit, Nicolas Rodondi, S. Streit, and Matthias Schwenkglenks. “Cost-Effectiveness of a Medication Review Intervention for General Practitioners and Their Multimorbid Older Patients with Polypharmacy: Analysis of Data from the OPTICA Trial.” Socio- Economic Planning Sciences, 2024. K. Jungo, Zsofia Rozsnyai, Sophie Mantelli, Carmen Floriani, A. Löwe, Fanny Lindemann, N. Schwab, et al. “‘Optimising PharmacoTherapy In the Multimorbid Elderly in Primary CAre’ (OPTICA) to Improve Medication Appropriateness: Study Protocol of a Cluster Randomised Controlled Trial.” BMJ Open, 2019.
K. Kyne, C. McCarthy, B. Kiely, Susan M. Smith, and B. Clyne. “Study Protocol for a Process Evalu- ation of a Cluster Randomised Controlled Trial to Reduce Potentially Inappropriate Prescribing and Polypharmacy in Patients with Multimorbidity in Irish Primary Care (SPPiRE).” HRB Open Research, 2019.
K. Potter, L. Flicker, A. Page, and C. Etherton-Beer. “Deprescribing in Frail Older People: A Randomised Controlled Trial.” PLoS ONE, 2016.
Kati Auvinen, Johanna Räisänen, A. Voutilainen, J. Jyrkkä, P. Mäntyselkä, and E. Lönnroos. “Interpro- fessional Medication Assessment Has Effects on the Quality of Medication Among Home Care Patients: Randomized Controlled Intervention Study.” Journal of the American Medical Directors Association, 2020.
L. Adam, E. Moutzouri, C. Baumgartner, A. Loewe, M. Feller, Khadija M'Rabet-Bensalah, N. Schwab, et al. “Rationale and Design of OPtimising thERapy to Prevent Avoidable Hospital Admissions in Multimorbid Older People (OPERAM): A Cluster Randomised Controlled Trial.” BMJ Open, 2019.
Marc-Eric Nadeau, Justine L. Henry, T. Lee, É. Bortolussi-Courval, Carole Goodine, and E. McDonald. “Spread and Scale of an Electronic Deprescribing Software to Improve Health Outcomes of Older Adults Living in Nursing Homes: Study Protocol for a Stepped Wedge Cluster Randomized Trial.” Trials, 2021. Marianne Lea, M. Mowé, E. Molden, K. Kvernrød, E. Skovlund, and L. Mathiesen. “Effect of Medicines Management Versus Standard Care on Readmissions in Multimorbid Patients: A Randomised Controlled Trial.” BMJ Open, 2020.
O. Krause, B. Wiese, Ina-Merle Doyle, Claudia Kirsch, P. Thürmann, S. Wilm, Lisa Sparenberg, et al. “Multidisciplinary Intervention to Improve Medication Safety in Nursing Home Residents: Protocol of a Cluster Randomised Controlled Trial (HIOPP-3-iTBX Study).” BMC Geriatrics, 2019.
P. Salari, C. O'Mahony, S. Henrard, P. Welsing, Arjun Bhadhuri, N. Schur, Marie Roumet, et al. “Cost- Effectiveness of a Structured Medication Review Approach for Multimorbid Older Adults: Within-Trial Analysis of the OPERAM Study.” PLoS ONE, 2022.
Qiwen Tang, Litao Wan, Jing Lu, Wenhui Wu, Huan Wu, Zhenwei Liu, Sitang Zhao, Chengyue Li, Gang Chen, and Jun Lu. “Rational Medication Management Mode and Its Implementation Effect for the Elderly with Multimorbidity: A Prospective Cohort Study in China.” Frontiers in Public Health, 2022.
Rita Romskaug, E. Molden, J. Straand, H. Kersten, E. Skovlund, K. Pitkala, and T. Wyller. “Coopera- tion Between Geriatricians and General Practitioners for Improved Pharmacotherapy in Home-Dwelling Elderly People Receiving Polypharmacy – the COOP Study: Study Protocol for a Cluster Randomised Controlled Trial.” Trials, 2017.
Rita Romskaug, E. Skovlund, J. Straand, E. Molden, H. Kersten, K. Pitkala, C. Lundqvist, and T. Wyller. “Effect of Clinical Geriatric Assessments and Collaborative Medication Reviews by Geriatrician and Fam- ily Physician for Improving Health-Related Quality of Life in Home-Dwelling Older Patients Receiving Polypharmacy: A Cluster Randomized Clinical Trial.” JAMA Internal Medicine, 2020.
S. Verdoorn, H. Kwint, J. Blom, J. Gussekloo, and M. Bouvy. “DREAMeR: Drug Use Reconsidered in the Elderly Using Goal Attainment Scales During Medication Review; Study Protocol of a Randomised Controlled Trial.” BMC Geriatrics, 2018.
———. “Effects of a Clinical Medication Review Focused on Personal Goals, Quality of Life, and Health Problems in Older Persons with Polypharmacy: A Randomised Controlled Trial (DREAMeR-Study).” PLoS Medicine, 2019.
Stefan Zechmann, O. Senn, F. Valeri, Stefan Essig, Christoph Merlo, T. Rosemann, and S. Neuner-Jehle. “Effect of a Patient-Centred Deprescribing Procedure in Older Multimorbid Patients in Swiss Primary Care - A Cluster-Randomised Clinical Trial.” BMC Geriatrics, 2020.
V. Dauphinot, E. Jean-bart, P. Krolak-Salmon, and C. Mouchoux. “A Multi-Center, Randomized, Controlled Trial to Assess the Efficacy of Optimization of Drug Prescribing in an Elderly Population, at 18 Months of Follow-up, in the Evolution of Functional Autonomy: The OPTIM Study Protocol.” BMC Geriatrics, 2017.
Wen-Shyong Liou, Shi-ming Huang, Wei-Hsin Lee, Yen-Lin Chang, and Ming-Fen Wu. “The Effects of a Pharmacist-Led Medication Review in a Nursing Home.” Medicine, 2021.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Calista Giovani, Yudhi Hajianto Nugroho, Mutia Juliana (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors publishing here keep copyright but grant the journal first publication rights, under a Creative Commons Attribution-NonCommercial 4.0 License. They can distribute their work non-exclusively elsewhere with an acknowledgment of its first publication in this journal. Posting the work online before and during submission for earlier and greater citation is encouraged, reflecting Open Access benefits.
